|
1.
Maxygen | Science & Technology | Publications Zhang Y.-X., Perry K., Vinci V.A., Powell K., Stemmer W.P.C. and del Cardayre S.B., Genome shuffling leads to rapid phenotypic improvement in bacteria ... 2.
Treatment of rheumatoid arthritis, CTLA4-Ig, Autoimmune disease ... Bristol-Myers Squibb has ongoing clinical studies of Orencia® for the treatment of other autoimmune diseases such as Crohn’s disease, lupus, psoriatic ... 3.
Treatment of rheumatoid arthritis, CTLA4-Ig, Autoimmune disease ... Clinical proof-of-concept for blocking T cell co-stimulation has already been demonstrated by Orencia®, which has been approved in the U.S., Canada and the ... 4.
Treatment of rheumatoid arthritis, CTLA4-Ig, Autoimmune disease ... The companies will co-develop MAXY-4 for rheumatoid arthritis and other autoimmune ... Like Orencia, MAXY-4 blocks the availability of B7 receptors, ... 5.
Microsoft PowerPoint - MAXY - Rodman Nov 2008 -final.ppt File Format: PDF/Adobe Acrobat - View as HTML Bone pain most frequent AE – severity comparable to Neulasta ... Neutropenia is typically 7-8 days w/out G-CSF support and 1.7-1.8 days w/ Neulasta support ... 6.
Maxygen Annual Report 2007 Because Neulasta® is patent-protected until 2015, our proprietary, patent-protected MAXY-G34 has an opportunity to become established before generics enter ... 7.
Maxygen Annual Report 2007 On July 15, 2003, the Company and a third party investor formed Avidia Inc. As of December 31, 2005, the Company had an equity interest of approximately 13% ... 8.
Maxygen Annual Report 2007 In July 2003, we established Avidia, Inc. (formerly Avidia Research Institute), or Avidia, a biotechnology company focused on developing products based on a ... 9.
Maxygen Annual Report 2007 Recent Accounting Pronouncements. On June 27, 2007, the Financial Accounting Standards Board (FASB) ratified the consensus reached by the FASB Emerging ... 10.
PowerPoint Presentation File Format: PDF/Adobe Acrobat - View as HTML MAXY-G34: A Superior PEGylated G-CSF. MAXY-G34 is the lead from a series of molecules ... MAXY-G34 is a modified G-CSF with directed PEGylation to optimize ... |
